Clovis Oncology Receives Notification of PDUFA Extension for Rociletinib
December 15, 2015 at 16:16 PM EST
Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug ...